Clinical Trial Update: Re-examination Study For Varivax (V210-059 AM2)

View source ↗

Summary

This clinical trial update reports the completion and posting of results for a re-examination study of Varivax (V210-059 AM2). The results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Varicella

Drugs mentioned

• Varivax (varicella vaccine (live attenuated))

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Varicella | Status: COMPLETED | Results posted: 2013-07-03